Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab vs Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
NCT00347698Phase 3Withdrawn
- Sponsor
- Asociación para Evitar la Ceguera en México
- Start
- Mar 2006
- Primary completion
- Mar 2006
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of bevacizumab in proliferative diabetic retinopathy (PDR), sponsored by Asociación para Evitar la Ceguera en México. Planned start Mar 2006; status: withdrawn.
02
Drugs
bevacizumab
03
Conditions
proliferative diabetic retinopathy (PDR)
Beyond the preview
Go deeper on NCT00347698.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00347698.